E-mail marketer Sili Neutraceuticals was fined more than$2.5 million by Federal district court of Northern Illinois for violating the Can-Spam Act by sending e-mails that contained misleading subject lines and didn’t offer an opt-out mechanism. The complaint said that Sili had been marketing Hoodia and human growth hormone supplements since 2004 via e-mail, which contained links to Web sites that made false claims about the product.
Related Posts
Artist Sheds New Light on Black Collegiate Life
Adraint Khadafhi Bereal, an artist with a unique blend of skills and techniques, is challenging the traditional image…
Startup Founders Advocate for Mental Health Support
Recognizing the mental toll financial downturns can have on startup founders, Naveed Lalani and Brad Baum have initiated…
Swiss National Bank Adjusts Strategy, Targets Forex Sector
In a strategic move to bolster their position in the global financial sector, the Swiss National Bank (SNB)…